Capital World Investors Exact Sciences Corp Transaction History

Capital World Investors

  • $625 Billion
  • Q3 2024

A detailed history of Capital World Investors transactions in Exact Sciences Corp stock. As of the latest transaction made, Capital World Investors holds 15,841,296 shares of EXAS stock, worth $781 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
15,841,296
Previous 16,501,346 4.0%
Holding current value
$781 Million
Previous $697 Million 54.71%
% of portfolio
0.17%
Previous 0.12%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$42.43 - $70.83 $28 Million - $46.8 Million
-660,050 Reduced 4.0%
15,841,296 $1.08 Billion
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $144 Million - $258 Million
3,476,033 Added 26.69%
16,501,346 $697 Million
Q1 2024

May 14, 2024
BUY
$56.27 - $73.77 $313 Million - $410 Million
5,557,168 Added 74.41%
13,025,313 $900 Million
Q4 2023

Feb 13, 2024
BUY
$59.06 - $75.72 $31.9 Million - $40.9 Million
539,498 Added 7.79%
7,468,145 $552 Million
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $8.62 Million - $12.9 Million
130,687 Added 1.92%
6,928,647 $473 Million
Q2 2023

Aug 11, 2023
BUY
$62.68 - $95.05 $10.9 Million - $16.5 Million
173,174 Added 2.61%
6,797,960 $638 Million
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $67.6 Million - $101 Million
1,433,399 Added 27.61%
6,624,786 $449 Million
Q4 2022

Feb 14, 2023
BUY
$30.35 - $53.15 $6 Million - $10.5 Million
197,698 Added 3.96%
5,191,387 $257 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $28.7 Million - $44.4 Million
-898,689 Reduced 15.25%
4,993,689 $162 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $14.4 Million - $30.9 Million
405,369 Added 7.39%
5,892,378 $232 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $46.3 Million - $66.4 Million
804,159 Added 17.17%
5,487,009 $384 Million
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $93.3 Million - $130 Million
-1,286,462 Reduced 21.55%
4,682,850 $364 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $34.6 Million - $47.6 Million
383,649 Added 6.87%
5,969,312 $570 Million
Q2 2021

Aug 16, 2021
SELL
$93.66 - $139.27 $264 Million - $393 Million
-2,822,123 Reduced 33.57%
5,585,663 $694 Million
Q1 2021

May 14, 2021
SELL
$116.57 - $155.01 $220 Million - $293 Million
-1,890,610 Reduced 18.36%
8,407,786 $1.11 Billion
Q4 2020

Feb 12, 2021
BUY
$99.61 - $142.12 $296 Million - $422 Million
2,967,886 Added 40.49%
10,298,396 $1.36 Billion
Q3 2020

Nov 13, 2020
BUY
$72.92 - $102.01 $470 Million - $657 Million
6,440,510 Added 723.65%
7,330,510 $747 Million
Q1 2018

May 15, 2018
SELL
$39.82 - $57.53 $34.2 Million - $49.5 Million
-860,000 Reduced 49.14%
890,000 $35.9 Million
Q3 2017

Nov 14, 2017
BUY
$37.05 - $47.12 $64.8 Million - $82.5 Million
1,750,000
1,750,000 $82.5 Million

Others Institutions Holding EXAS

# of Institutions
671
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email